[HTML][HTML] Immune-protective formulations and process strategies for improved survival and function of transplanted islets

Y Shi, YZ Zhao, Z Jiang, Z Wang, Q Wang… - Frontiers in …, 2022 - frontiersin.org
Type 1 diabetes (T1D) is an autoimmune disease caused by the immune system attacking
and destroying insulin-producing β cells in the pancreas. Islet transplantation is becoming …

Bio-synthetic materials for immunomodulation of islet transplants

GA Foster, AJ García - Advanced drug delivery reviews, 2017 - Elsevier
Clinical islet transplantation is an effective therapy in restoring physiological glycemic
control in type 1 diabetics. However, allogeneic islets derived from cadaveric sources elicit …

Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery

TR Lansberry, CL Stabler - Advanced drug delivery reviews, 2024 - Elsevier
Type 1 diabetes mellitus (T1DM) is an autoimmune condition that results in the destruction of
insulin-secreting β cells of the islets of Langerhans. Allogeneic islet transplantation could be …

Nanotechnology approaches to modulate immune responses to cell-based therapies for type 1 diabetes

SC Wiggins, NJ Abuid… - Journal of Diabetes …, 2020 - journals.sagepub.com
Islet transplantation is a promising curative treatment option for type 1 diabetes (T1D) as it
can provide physiological blood glucose control. The widespread utilization of islet …

Immunoisolation of pancreatic islets via thin-layer surface modification

S Pathak, TT Pham, JH Jeong, Y Byun - Journal of Controlled Release, 2019 - Elsevier
Islet transplantation is an alternative method of replacing exogenous insulin to treat type 1
diabetes. However, transplantation of allo-or xenograft islets causes the activation of host's …

Rational engineering of islet tolerance via biomaterial-mediated immune modulation

N Klug, J Burke, E Scott - The Journal of Immunology, 2024 - journals.aai.org
Abstract Type 1 diabetes (T1D) onset is characterized by an autoimmune attack on β islet
cells within the pancreas, preventing the insulin secretion required to maintain glucose …

Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells

X Wang, NK Brown, B Wang, K Shariati… - Advanced …, 2021 - Wiley Online Library
Islet transplantation has shown promise as a curative therapy for type 1 diabetes (T1D).
However, the side effects of systemic immunosuppression and limited long‐term viability of …

[HTML][HTML] Advancements in innate immune regulation strategies in islet transplantation

K Duan, J Liu, J Zhang, T Chu, H Liu, F Lou… - Frontiers in …, 2024 - frontiersin.org
As a newly emerging organ transplantation technique, islet transplantation has shown the
advantages of minimal trauma and high safety since it was first carried out. The proposal of …

Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes

MM Samojlik, CL Stabler - Acta biomaterialia, 2021 - Elsevier
The effective suppression of adaptive immune responses is essential for the success of
allogeneic cell therapies. In islet transplantation for Type 1 Diabetes, pre-existing …

Engineering strategies to improve islet transplantation for type 1 diabetes therapy

AM White, JG Shamul, J Xu, S Stewart… - ACS biomaterials …, 2019 - ACS Publications
Type 1 diabetes is an autoimmune disease in which the immune system attacks insulin-
producing beta cells of pancreatic islets. Type 1 diabetes can be treated with islet …